How to quit cannabis when you have a mental illness: study from the perspective of patients who have successfully quit

被引:3
|
作者
Bruins, Jojanneke [1 ,2 ]
Crutzen, Stijn [1 ,2 ]
Veling, Wim [2 ]
Castelein, Stynke [1 ,2 ]
机构
[1] Lentis Psychiat Inst, Groningen, Netherlands
[2] Univ Groningen, Groningen, Netherlands
来源
BJPSYCH BULLETIN | 2024年 / 48卷 / 04期
关键词
Comorbidity; substance use disorders; qualitative research; severe mental illness; marijuana; QUALITY-OF-LIFE; SUBSTANCE USE; USE DISORDERS; PSYCHOSIS; INDIVIDUALS; PEOPLE; ASSOCIATION; REASONS; HEALTH; TRIAL;
D O I
10.1192/bjb.2023.69
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Aims and method Research regarding quitting cannabis use often excludes patients with severe mental illness (SMI). We investigated facilitating and impeding factors in SMI patients and their advice to others, using semi-structured interviews with 12 SMI-patients, who were daily cannabis users for >= 12 months and had fully stopped using for >= 6 months.Results Seeking distraction, social contacts in personal environment, avoiding temptation and support from professionals were facilitating factors in stopping. Impeding factors were withdrawal symptoms, user environment, experiencing stress and user's routine. Advice to other patients included to just do it, seek support from others, quit 'cold turkey' and acknowledge that cannabis use is a problem. Advice to mental health professionals is to discuss cannabis use from the start of treatment.Clinical implications It is important to inform patients that cannabis use has negative consequences and limits the effects of treatment. Do not judge cannabis use or force the patient to stop.
引用
收藏
页码:234 / 240
页数:7
相关论文
共 29 条
  • [21] Who have a better-kidney-related quality of life: peritoneal dialysis or hemodialysis patients? A cross sectional study from Saudi Arabia
    Mohammed Alshehri
    Abdullah Alshehri
    Ali Alfageeh
    Khalid Asiri
    Alwaleed Alshehri
    Feras Alqahtani
    Mazen Alshehri
    Mohanad Alshabab
    Omar Asiri
    BMC Nephrology, 24
  • [22] Who have a better-kidney-related quality of life: peritoneal dialysis or hemodialysis patients? A cross sectional study from Saudi Arabia
    Alshehri, Mohammed
    Alshehri, Abdullah
    Alfageeh, Ali
    Asiri, Khalid
    Alshehri, Alwaleed
    Alqahtani, Feras
    Alshehri, Mazen
    Alshabab, Mohanad
    Asiri, Omar
    BMC NEPHROLOGY, 2023, 24 (01)
  • [23] Place of death and factors associated with hospital death in patients who have died from liver disease in England: a national population-based study
    Peng, Jen-Kuei
    Higginson, Irene J.
    Gao, Wei
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (01): : 52 - 62
  • [24] The relationship of social support, mental health, and health-related quality of life in human immunodeficiency virus-positive men who have sex with men: From the analysis of canonical correlation and structural equation model: A cross-sectional study
    Shao, Bing
    Song, Bo
    Feng, Shiyan
    Lin, Yuanlong
    Du, Juan
    Shao, Hong
    Chi, Zong
    Yang, Yanze
    Wang, Fuxiang
    MEDICINE, 2018, 97 (30)
  • [25] Serious diabetes-specific emotional problems in patients with type 2 diabetes who have different levels of comorbid depression: A Polish study from the European Depression in Diabetes (EDID) Research Consortium
    Kokoszka, A.
    Pouwer, F.
    Jodko, A.
    Radzio, R.
    Mucko, P.
    Bienkowska, J.
    Kuligowska, E.
    Smoczynska, O.
    Sklodowska, Z.
    EUROPEAN PSYCHIATRY, 2009, 24 (07) : 425 - 430
  • [26] Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial
    Forde, Caroline
    McMullan, Ronan
    Clarke, Mike
    Wilson, Richard H.
    Plummer, Ruth
    Grayson, Margaret
    McDowell, Cliona
    Agus, Ashley
    Doran, Annmarie
    McAuley, Danny F.
    Thomas, Anne L.
    Barnes, Rosemary A.
    Adams, Richard
    Chau, Ian
    Coyle, Vicky
    TRIALS, 2020, 21 (01)
  • [27] Rituximab-PECC induction followed by 90Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study
    Lugtenburg, Pieternella J.
    Zijlstra, Josee M.
    Doorduijn, Jeanette K.
    Bohmer, Lara H.
    Hoogendoorn, Mels
    Berenschot, Henriette W.
    Beeker, Aart
    van der Burg-de Graauw, Nicole C.
    Schouten, Harry C.
    Bilgin, Yavuz M.
    Kersten, Marie-Jose
    Koene, Harry R.
    Herbers, Alexandra H. E.
    de Jong, Daphne
    Hijmering, Nathalie
    Lam, King H.
    Chitu, Dana
    Brouwer, Rolf E.
    van Imhoff, Gustaaf W.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (03) : 347 - 355
  • [28] Compromised quality of life in adult patients who have received a radiation dose towards the basal part of the brain. A case-control study in long-term survivors from cancer in the head and neck region
    Lofdahl, Elisabet
    Berg, Gertrud
    Johansson, Karl-Axel
    Zachrisson, Maria Leonsson
    Malmgren, Helge
    Mercke, Claes
    Olsson, Erik
    Wiren, Lena
    Johannsson, Gudmundur
    RADIATION ONCOLOGY, 2012, 7
  • [29] Compromised quality of life in adult patients who have received a radiation dose towards the basal part of the brain. A case-control study in long-term survivors from cancer in the head and neck region
    Elisabet Löfdahl
    Gertrud Berg
    Karl-Axel Johansson
    Maria Leonsson Zachrisson
    Helge Malmgren
    Claes Mercke
    Erik Olsson
    Lena Wiren
    Gudmundur Johannsson
    Radiation Oncology, 7